DK0612318T3 - Heteroarylpiperidiner, -pyrrolidiner og -piperaziner samt deres anvendelse som antipsykotika og analgetika - Google Patents
Heteroarylpiperidiner, -pyrrolidiner og -piperaziner samt deres anvendelse som antipsykotika og analgetikaInfo
- Publication number
- DK0612318T3 DK0612318T3 DK92924151T DK92924151T DK0612318T3 DK 0612318 T3 DK0612318 T3 DK 0612318T3 DK 92924151 T DK92924151 T DK 92924151T DK 92924151 T DK92924151 T DK 92924151T DK 0612318 T3 DK0612318 T3 DK 0612318T3
- Authority
- DK
- Denmark
- Prior art keywords
- pyrrolidines
- piperazines
- analgesics
- heteroberl
- antipsychotics
- Prior art date
Links
- 239000000730 antalgic agent Substances 0.000 title abstract 3
- 229940035676 analgesics Drugs 0.000 title abstract 2
- 239000000164 antipsychotic agent Substances 0.000 title abstract 2
- 150000004885 piperazines Chemical class 0.000 title abstract 2
- 150000003235 pyrrolidines Chemical class 0.000 title abstract 2
- 229940005529 antipsychotics Drugs 0.000 title 1
- 150000003053 piperidines Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 241000124008 Mammalia Species 0.000 abstract 2
- 208000028017 Psychotic disease Diseases 0.000 abstract 2
- 230000000561 anti-psychotic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/24—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
- C07C233/25—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/30—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms
- C07C233/33—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/22—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and doubly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
- C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
- C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/82—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78826991A | 1991-11-05 | 1991-11-05 | |
US07/969,383 US5364866A (en) | 1989-05-19 | 1992-10-30 | Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics |
PCT/US1992/009276 WO1993009102A1 (en) | 1991-11-05 | 1992-11-04 | Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0612318T3 true DK0612318T3 (da) | 2003-12-08 |
Family
ID=27120778
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK99111017T DK0959076T3 (da) | 1991-11-05 | 1992-11-04 | Heteroarylpiperidiner, -pyrroliner og -piperaziner og deres anvendelse som antipsykotiske og analgetiske midler |
DK99111314.3T DK0959075T3 (da) | 1991-11-05 | 1992-11-04 | Heteroarylpiperidiner og piperaziner og deres anvendelse som antipsykotiske og analgetiske midler |
DK92924151T DK0612318T3 (da) | 1991-11-05 | 1992-11-04 | Heteroarylpiperidiner, -pyrrolidiner og -piperaziner samt deres anvendelse som antipsykotika og analgetika |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK99111017T DK0959076T3 (da) | 1991-11-05 | 1992-11-04 | Heteroarylpiperidiner, -pyrroliner og -piperaziner og deres anvendelse som antipsykotiske og analgetiske midler |
DK99111314.3T DK0959075T3 (da) | 1991-11-05 | 1992-11-04 | Heteroarylpiperidiner og piperaziner og deres anvendelse som antipsykotiske og analgetiske midler |
Country Status (25)
Country | Link |
---|---|
US (4) | US5364866A (ru) |
EP (8) | EP1110954A1 (ru) |
JP (1) | JP2927551B2 (ru) |
KR (1) | KR100276764B1 (ru) |
AT (3) | ATE485293T1 (ru) |
AU (1) | AU674499B2 (ru) |
CA (1) | CA2121253C (ru) |
CZ (1) | CZ287611B6 (ru) |
DE (3) | DE69233796D1 (ru) |
DK (3) | DK0959076T3 (ru) |
ES (3) | ES2206450T3 (ru) |
FI (2) | FI942052A (ru) |
GE (1) | GEP19991706B (ru) |
HK (2) | HK1023775A1 (ru) |
HU (1) | HUT70855A (ru) |
IL (1) | IL103622A (ru) |
NO (1) | NO304979B1 (ru) |
NZ (1) | NZ245006A (ru) |
PH (1) | PH30432A (ru) |
PT (2) | PT542136E (ru) |
RO (1) | RO114447B1 (ru) |
RU (1) | RU2127731C1 (ru) |
SK (1) | SK283517B6 (ru) |
UA (1) | UA41289C2 (ru) |
WO (1) | WO1993009102A1 (ru) |
Families Citing this family (69)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5776963A (en) * | 1989-05-19 | 1998-07-07 | Hoechst Marion Roussel, Inc. | 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility |
US5364866A (en) | 1989-05-19 | 1994-11-15 | Hoechst-Roussel Pharmaceuticals, Inc. | Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics |
US5561128A (en) * | 1989-05-19 | 1996-10-01 | Hoechst-Roussel Pharmaceuticals, Inc. | N-[(4-(heteroaryl)-1-piperidinyl)alkyl]-10,11-dihydro-5H-dibenz[B,F]azepines and related compounds and their therapeutic utility |
US5750542A (en) | 1993-09-28 | 1998-05-12 | Pfizer | Benzisoxazole and benzisothizole derivatives as cholinesterase inhibitors |
US5494908A (en) * | 1992-11-23 | 1996-02-27 | Hoechst-Roussel Pharmaceutical Incorporated | Substituted 3-(aminoalkylamino)-1,2-benzisoxazoles and related compounds |
NZ258747A (en) * | 1992-11-23 | 1997-02-24 | Hoechst Marion Roussel Inc Sub | 3-heterocyclyalkylamino benzisoxazole derivatives; medicaments |
GB9410031D0 (en) * | 1994-05-19 | 1994-07-06 | Merck Sharp & Dohme | Therapeutic agents |
DK0833820T3 (da) * | 1995-06-06 | 2001-04-17 | Aventis Pharma Inc | Benzisoxazol- og indazolderivater som antipsykotiske midler |
CA2262906C (en) * | 1996-08-12 | 2006-10-31 | Celgene Corporation | Novel immunotherapeutic agents and their use in the reduction of cytokine levels |
DE60235130D1 (de) * | 2001-02-16 | 2010-03-04 | Aventis Pharma Inc | Heterocyclische substituierte carbonyl Derivate und ihre Verwendung als Dopamin D3 rezeptor Liganden |
GB0117577D0 (en) | 2001-02-16 | 2001-09-12 | Aventis Pharm Prod Inc | Novel heterocyclic substituted carbonyl derivatives and their use as dopamine D receptor ligands |
FR2827280B1 (fr) * | 2001-07-13 | 2003-10-31 | Servier Lab | Nouveaux derives de benzene sulfonamide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
EP1425272B1 (en) | 2001-08-31 | 2011-08-03 | Novartis AG | Optical isomers of an iloperidone metabolite |
US7355042B2 (en) * | 2001-10-16 | 2008-04-08 | Hypnion, Inc. | Treatment of CNS disorders using CNS target modulators |
CN101912367A (zh) * | 2001-10-30 | 2010-12-15 | 诺瓦提斯公司 | 伊潘立酮和星状聚合物的贮库制剂 |
WO2003070247A1 (en) * | 2002-02-20 | 2003-08-28 | Abbott Laboratories | Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor |
GB0216416D0 (en) | 2002-07-15 | 2002-08-21 | Novartis Ag | Organic compounds |
US6939877B2 (en) | 2002-09-12 | 2005-09-06 | Wyeth | Antidepressant piperidine derivatives of heterocycle-fused benzodioxans |
OA12923A (en) * | 2002-09-17 | 2006-10-13 | Warner Lambert Co | Heterocyclic substituted piperazines for the treatment of schizophrenia. |
EP1546145A1 (en) * | 2002-09-26 | 2005-06-29 | Warner-Lambert Company Llc | Heterocyclic substituted piperazines for the treatment of schizophrenia |
US7157471B2 (en) * | 2003-08-25 | 2007-01-02 | Boehringer Ingelheim International Gmbh | Haloalkyl- and piperidine-substituted benzimidazole-derivatives |
GB0322994D0 (en) * | 2003-10-01 | 2003-11-05 | Novartis Ag | Organic compounds |
EP1697334A1 (en) * | 2003-12-08 | 2006-09-06 | Warner-Lambert Company LLC | Heterocyclic substituted indane derivatives and related compounds for the treatment of schizophrenia |
US20100063093A1 (en) * | 2007-03-28 | 2010-03-11 | Curt Wolfgang | Methods for the administration of iloperidone |
WO2006039663A2 (en) | 2004-09-30 | 2006-04-13 | Vanda Pharmaceuticals, Inc | Methods for the administration of iloperidone |
EP1877390B1 (en) * | 2005-04-26 | 2010-03-24 | Hypnion, Inc. | Benzisoxazole piperazine compounds and methods of use thereof |
WO2007098418A1 (en) * | 2006-02-17 | 2007-08-30 | Memory Pharmaceuticals Corporation | Compounds having 5-ht6 receptor affinity |
JP2009538331A (ja) * | 2006-05-22 | 2009-11-05 | ヴァンダ ファーマシューティカルズ インコーポレイテッド | 抑うつ障害のための治療 |
US20150259747A1 (en) | 2007-03-29 | 2015-09-17 | Vanda Pharmaceuticals Inc. | Method of predicting a predisposition to qt prolongation |
ES2542967T3 (es) | 2007-03-29 | 2015-08-13 | Vanda Pharmaceuticals Inc. | Método de predecir una predisposición a la prolongación de QT |
WO2008128166A1 (en) * | 2007-04-13 | 2008-10-23 | Concert Pharmaceuticals Inc. | Deuterated derivatives of 4-(6-fluoro-1, 2-benzisoxazol-3-yl) piperidine compounds |
ES2569480T3 (es) | 2007-05-18 | 2016-05-11 | Vanda Pharmaceuticals Inc. | Marcadores genéticos de eficacia de iloperidona en el tratamiento de síntomas psicóticos |
RU2480466C2 (ru) * | 2007-07-26 | 2013-04-27 | Ф.Хоффманн-Ля Рош Аг | Двойные модуляторы 5-ht2a и d3-рецепторов |
US20090069337A1 (en) * | 2007-08-15 | 2009-03-12 | Memory Pharmaceuticals Corporation | 3' substituted compounds having 5-ht6 receptor affinity |
CA2698534C (en) * | 2007-09-10 | 2018-10-09 | Vanda Pharmaceuticals, Inc. | Prediction of qt prolongation based on snp genotype |
DK2222300T3 (da) | 2007-12-13 | 2014-07-21 | Vanda Pharmaceuticals Inc | Fremgangsmåde og præparat til behandling af en serotoninreceptormedieret tilstand |
JP5729808B2 (ja) | 2007-12-13 | 2015-06-03 | ヴァンダ ファーマシューティカルズ インコーポレイテッド | αアドレナリン受容体介在状態を治療する方法及び組成物 |
US20100016297A1 (en) * | 2008-06-24 | 2010-01-21 | Memory Pharmaceuticals Corporation | Alkyl-substituted 3' compounds having 5-ht6 receptor affinity |
US20100029629A1 (en) * | 2008-07-25 | 2010-02-04 | Memory Pharmaceuticals Corporation | Acyclic compounds having 5-ht6 receptor affinity |
US20100056531A1 (en) * | 2008-08-22 | 2010-03-04 | Memory Pharmaceuticals Corporation | Alkyl-substituted 3' compounds having 5-ht6 receptor affinity |
JP5881597B2 (ja) | 2009-04-06 | 2016-03-09 | ヴァンダ ファーマシューティカルズ インコーポレイテッド | Qt延長に対する素因を予測する方法 |
JP5881598B2 (ja) | 2009-04-06 | 2016-03-09 | ヴァンダ ファーマシューティカルズ インコーポレイテッド | Abcc2遺伝子の配列又はその産物に基づいてqt延長に対する素因を予測する方法 |
EP3354753B1 (en) | 2009-04-06 | 2020-02-12 | Vanda Pharmaceuticals Inc. | Method of treatment based on polymorphisms of the kcnq1 gene |
JP5692872B2 (ja) | 2009-04-06 | 2015-04-01 | ヴァンダ ファーマシューティカルズ インコーポレイテッド | Bai遺伝子の配列又はその産物に基づいてqt延長に対する素因を予測する方法 |
DE102009017729A1 (de) | 2009-04-11 | 2010-10-14 | Fleissner Gmbh | Vorrichtung zum Verfestigen einer Faserbahn |
DE102009016996A1 (de) | 2009-04-08 | 2010-10-14 | Fleissner Gmbh | Vorrichtung zum Verfestigen einer Faserbahn |
DE102009032343A1 (de) | 2009-07-09 | 2011-01-20 | Fleissner Gmbh Und Co. | Vorrichtung zum Verfestigen einer Materialbahn |
WO2011032404A1 (zh) * | 2009-09-19 | 2011-03-24 | 浙江华海药业股份有限公司 | 伊潘立酮的一种制备方法及结晶方法 |
WO2011055188A1 (en) * | 2009-11-05 | 2011-05-12 | Orchid Chemicals And Pharmaceuticals Limited | An improved process for the preparation of iloperidone |
US20120220776A1 (en) * | 2009-11-19 | 2012-08-30 | Symed Labs Limited | Process for the preparation of iloperidone using a novel intermediate |
WO2011077239A2 (en) | 2009-12-23 | 2011-06-30 | Lupin Limited | Slow release pharmaceutical compositions of iloperidone |
AU2010339689B2 (en) | 2010-01-07 | 2015-02-19 | Alkermes Pharma Ireland Limited | Quaternary ammonium salt prodrugs |
US8343706B2 (en) * | 2010-01-25 | 2013-01-01 | International Business Machines Corporation | Fluorine-free fused ring heteroaromatic photoacid generators and resist compositions containing the same |
DE102010009275A1 (de) | 2010-02-25 | 2011-08-25 | Trützschler Nonwovens GmbH, 63329 | Vorrichtung zum Verfestigen einer Materialbahn |
WO2011154860A1 (en) * | 2010-06-08 | 2011-12-15 | Alembic Pharmaceuticals Limited | An improved process for preparing iloperidone |
US9000221B2 (en) * | 2010-09-07 | 2015-04-07 | Symed Labs Limited | Processes for the preparation of 4′-[3-[4-(6-Fluoro-1 ,2-benzisoxazol-3-yl)piperidino]propoxy]-3′-methoxyacetophenone and intermediates thereof |
WO2012090138A1 (en) * | 2010-12-27 | 2012-07-05 | Ranbaxy Laboratories Limited | Processes for the preparation of iloperidone |
WO2012123963A2 (en) | 2011-02-24 | 2012-09-20 | Megafine Pharma (P) Ltd. | A process for preparation of iloperidone and amorphous co- precipitate of iloperidone with pharmaceutically acceptable excipient |
JP2015510893A (ja) | 2012-03-14 | 2015-04-13 | ヴァンダ ファーマシューティカルズ インコーポレイテッド | 精神障害の治療における使用のためのイロペリドン代謝物 |
US9375433B2 (en) * | 2012-09-26 | 2016-06-28 | Tangent Reprofiling Limited | Modulators of androgen synthesis |
US20140206667A1 (en) | 2012-11-14 | 2014-07-24 | Michela Gallagher | Methods and compositions for treating schizophrenia |
CN103012387B (zh) * | 2012-12-26 | 2015-08-12 | 浙江大学 | 伊潘立酮的制备方法 |
US10806717B2 (en) | 2013-03-15 | 2020-10-20 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
US11160785B2 (en) | 2013-03-15 | 2021-11-02 | Agenebio Inc. | Methods and compositions for improving cognitive function |
CN103319472B (zh) * | 2013-07-23 | 2016-07-06 | 河北科技大学 | 一种伊潘立酮的制备方法 |
JP6899043B2 (ja) | 2015-05-22 | 2021-07-07 | エージンバイオ, インコーポレイテッド | レベチラセタムの持続放出性医薬組成物 |
CN113164382A (zh) | 2018-12-04 | 2021-07-23 | 万达制药公司 | 伊潘立酮的贮库施用 |
US11607408B2 (en) | 2019-10-15 | 2023-03-21 | Vanda Pharmaceuticals Inc. | Method of treatment of schizophrenia |
WO2023201182A1 (en) | 2022-04-13 | 2023-10-19 | Vanda Pharmaceuticals Inc. | Treatment of parkinson's disease and parkinson's disease psychosis |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2258843B1 (ru) * | 1974-01-30 | 1977-09-09 | Roussel Uclaf | |
US4335127A (en) * | 1979-01-08 | 1982-06-15 | Janssen Pharmaceutica, N.V. | Piperidinylalkyl quinazoline compounds, composition and method of use |
US4355037A (en) * | 1981-11-12 | 1982-10-19 | Hoechst-Roussel Pharmaceuticals | 3-(4-Piperidyl)-1,2-benzisoxales |
US4458076A (en) * | 1983-05-31 | 1984-07-03 | Hoechst-Roussel Pharmaceuticals | 3-(4-Piperidinyl)-1,2-benzisothiazoles |
US4670447A (en) * | 1983-08-22 | 1987-06-02 | Hoechst-Roussel Pharmaceuticals Inc. | Antipsychotic 3-(piperidinyl)- and 3-(pyrrolidinyl)-1H-indazoles |
HU198036B (en) * | 1983-08-22 | 1989-07-28 | Hoechst Roussel Pharma | Process for production of derivatives of 3-piperidil-/1h/-indasole and medical preparatives containing them |
US4590196A (en) * | 1984-08-23 | 1986-05-20 | Bristol-Myers Company | Analgesic 1,2-benzisothiazol-3-ylpiperazine derivatives |
JPH0625181B2 (ja) * | 1985-03-27 | 1994-04-06 | 住友製薬株式会社 | 新規なイミド誘導体 |
JP2660407B2 (ja) * | 1986-09-26 | 1997-10-08 | 住友製薬株式会社 | 新規なイミド誘導体 |
EP0302423A3 (en) | 1987-08-07 | 1991-01-09 | Hoechst-Roussel Pharmaceuticals Incorporated | 1-phenyl-3-(1-piperazinyl)-1h-indazoles, a process and intermediates for their preparation, and the use thereof as medicaments |
US4999356A (en) * | 1987-08-07 | 1991-03-12 | Hoechst-Roussel Pharmaceuticals, Inc. | 1-phenyl-3-(1-piperazinyl)-1H-indazoles |
JPH01199967A (ja) * | 1987-10-26 | 1989-08-11 | Sumitomo Pharmaceut Co Ltd | 新規なイミド誘導体 |
CA1335289C (en) * | 1987-10-26 | 1995-04-18 | Fujio Antoku | Piperidinyl benzisoxazole derivatives, their production and pharmaceutical use |
US4880930A (en) | 1987-11-30 | 1989-11-14 | New James S | Psychotropic acyclic amide derivatives |
US5001130A (en) * | 1988-02-18 | 1991-03-19 | Bristol-Myers Company | Psychotropic heterobicycloalkylpiperazine derivatives |
US4780466A (en) * | 1988-03-17 | 1988-10-25 | Hoechst-Roussel Pharmaceuticals, Inc. | Arylpiperazinylalkoxy derivatives of cyclic imides |
NZ230045A (en) * | 1988-08-05 | 1990-11-27 | Janssen Pharmaceutica Nv | 3-piperazinylbenzazole derivatives and pharmaceutical compositions |
IL90879A0 (en) | 1988-09-02 | 1990-02-09 | Janssen Pharmaceutica Nv | 3-piperidinyl-indazole derivatives,their preparation and antihypertensive compositions containing them |
FR2641278B1 (fr) * | 1989-01-05 | 1991-03-22 | Lipha | Piperidines, procedes de preparation et medicaments les contenant |
NZ233525A (en) | 1989-05-15 | 1991-09-25 | Janssen Pharmaceutica Nv | Piperidinyl, pyrrolidinyl and piperazinyl alkylphenol ethers and pharmaceutical compositions |
NZ233503A (en) | 1989-05-15 | 1991-06-25 | Janssen Pharmaceutica Nv | Substituted (thio)morpholinyl and piperazinyl alkylphenol ethers |
DE69021645T2 (de) * | 1989-05-19 | 1996-02-22 | Hoechst Roussel Pharma | N-(aryloxyalkyl)heteroarylpiperidine und -heteroarylpiperazine, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikamente. |
US5364866A (en) | 1989-05-19 | 1994-11-15 | Hoechst-Roussel Pharmaceuticals, Inc. | Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics |
US4954503A (en) * | 1989-09-11 | 1990-09-04 | Hoechst-Roussel Pharmaceuticals, Inc. | 3-(1-substituted-4-piperazinyl)-1H-indazoles |
US4968792A (en) * | 1989-09-25 | 1990-11-06 | American Home Products Corporation | Psychotropic benzisothiazole derivatives |
JP2800953B2 (ja) * | 1990-07-06 | 1998-09-21 | 住友製薬株式会社 | 新規なイミド誘導体 |
JPH07500550A (ja) | 1991-10-31 | 1995-01-19 | アライド−シグナル・インコーポレーテッド | 電気油圧式ブレーキシステム |
GB9202915D0 (en) * | 1992-02-12 | 1992-03-25 | Wellcome Found | Chemical compounds |
GB9302622D0 (en) | 1993-02-10 | 1993-03-24 | Wellcome Found | Heteroaromatic compounds |
-
1992
- 1992-10-30 US US07/969,383 patent/US5364866A/en not_active Ceased
- 1992-11-03 IL IL10362292A patent/IL103622A/ not_active IP Right Cessation
- 1992-11-03 NZ NZ245006A patent/NZ245006A/en not_active IP Right Cessation
- 1992-11-04 KR KR1019940701524A patent/KR100276764B1/ko not_active IP Right Cessation
- 1992-11-04 JP JP5508591A patent/JP2927551B2/ja not_active Expired - Lifetime
- 1992-11-04 EP EP01102643A patent/EP1110954A1/en not_active Withdrawn
- 1992-11-04 RO RO94-00761A patent/RO114447B1/ro unknown
- 1992-11-04 AU AU30570/92A patent/AU674499B2/en not_active Expired
- 1992-11-04 AT AT99111314T patent/ATE485293T1/de active
- 1992-11-04 EP EP99111017A patent/EP0959076B1/en not_active Expired - Lifetime
- 1992-11-04 UA UA94005421A patent/UA41289C2/ru unknown
- 1992-11-04 GE GEAP19922829A patent/GEP19991706B/en unknown
- 1992-11-04 ES ES92924151T patent/ES2206450T3/es not_active Expired - Lifetime
- 1992-11-04 ES ES99111314T patent/ES2354407T3/es not_active Expired - Lifetime
- 1992-11-04 HU HU9401316A patent/HUT70855A/hu unknown
- 1992-11-04 AT AT99111017T patent/ATE356123T1/de active
- 1992-11-04 RU RU94028105/04A patent/RU2127731C1/ru active
- 1992-11-04 DE DE69233796T patent/DE69233796D1/de not_active Expired - Lifetime
- 1992-11-04 AT AT92924151T patent/ATE248825T1/de active
- 1992-11-04 CA CA002121253A patent/CA2121253C/en not_active Expired - Lifetime
- 1992-11-04 SK SK456-94A patent/SK283517B6/sk not_active IP Right Cessation
- 1992-11-04 DK DK99111017T patent/DK0959076T3/da active
- 1992-11-04 EP EP99111314A patent/EP0959075B1/en not_active Expired - Lifetime
- 1992-11-04 DK DK99111314.3T patent/DK0959075T3/da active
- 1992-11-04 EP EP92924151A patent/EP0612318B1/en not_active Expired - Lifetime
- 1992-11-04 DK DK92924151T patent/DK0612318T3/da active
- 1992-11-04 CZ CZ19941102A patent/CZ287611B6/cs not_active IP Right Cessation
- 1992-11-04 ES ES99111017T patent/ES2283087T3/es not_active Expired - Lifetime
- 1992-11-04 DE DE69233686T patent/DE69233686T2/de not_active Expired - Lifetime
- 1992-11-04 WO PCT/US1992/009276 patent/WO1993009102A1/en active IP Right Grant
- 1992-11-04 DE DE69233189T patent/DE69233189T2/de not_active Expired - Lifetime
- 1992-11-05 PT PT92118982T patent/PT542136E/pt unknown
- 1992-11-05 EP EP99111315A patent/EP0963984B1/en not_active Expired - Lifetime
- 1992-11-05 EP EP00115401A patent/EP1052255A1/en not_active Withdrawn
- 1992-11-05 EP EP92118982A patent/EP0542136B1/en not_active Expired - Lifetime
- 1992-11-05 PT PT99111315T patent/PT963984E/pt unknown
- 1992-11-05 EP EP99111016A patent/EP0957102A1/en not_active Withdrawn
- 1992-11-12 PH PH45259A patent/PH30432A/en unknown
-
1994
- 1994-05-04 FI FI942052A patent/FI942052A/fi not_active Application Discontinuation
- 1994-05-04 NO NO941647A patent/NO304979B1/no not_active IP Right Cessation
- 1994-09-20 US US08/309,395 patent/US5658911A/en not_active Ceased
-
2000
- 2000-05-22 HK HK00103040.4A patent/HK1023775A1/ not_active IP Right Cessation
- 2000-05-22 HK HK00103045A patent/HK1023776A1/xx not_active IP Right Cessation
- 2000-11-09 US US09/708,475 patent/USRE39265E1/en not_active Expired - Lifetime
- 2000-11-15 US US09/712,129 patent/USRE39198E1/en not_active Expired - Lifetime
-
2010
- 2010-05-10 FI FI20100200A patent/FI20100200A/fi not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0612318T3 (da) | Heteroarylpiperidiner, -pyrrolidiner og -piperaziner samt deres anvendelse som antipsykotika og analgetika | |
CA2175212A1 (en) | Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics | |
RU94028105A (ru) | Новые гетероарилпроизводные, промежуточные соединения для их получения, фармкомпозиция на их основе, способ лечения психозов и способ облегчения боли | |
GB9406857D0 (en) | Improvements in or relating to organic compounds | |
DK0772603T3 (da) | Substituerede pyrimidinforbindelser og deres anvendelse | |
DE69210622T2 (de) | Zusammensetzung zum stabilisieren anorganischer peroxidlösungen | |
HUT71550A (en) | Pharmaceutical agents containing quinuclidine, piperidine or azanorbornane derivatives for treatment of emesis | |
DK0694545T3 (da) | Substituerede dibenzoxazepinforbindelser, farmaceutiske sammensætninger og anvendelsesmetoder | |
SE7611137L (sv) | 1-bensazolylalkyl-4-substituerade piperidiner | |
FI891473A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 4-aryyli-4-piperidiinikarbinolien valmistamiseksi | |
ATE100465T1 (de) | Analoge von bradykinin, dessen synthese und dessen benutzung in der therapie. | |
GR3014927T3 (en) | Disubstituted piperidines and pyrrolidines as anticholinergic agents. | |
DE69719218D1 (de) | Verwendung von pvp oder povidone zum reduzieren von darmschwellungen | |
DE69431118T2 (de) | Fungizide, hautkosmetishe zusammensetzung | |
ES2119581A1 (es) | Utilizacion de fragmentos de timosina y/o sus derivados |